Skip to main content
LUYE PHARMA GROUP LTD. logo

LUYE PHARMA GROUP LTD. — Investor Relations & Filings

Ticker · 1M4B ISIN · XS2927538962 SGX Manufacturing
Filings indexed 5 across all filing types
Latest filing 2025-09-10 Regulatory Filings
Country SG Singapore
Listing SGX 1M4B

About LUYE PHARMA GROUP LTD.

https://www.luye.cn/lvye_en/

LUYE PHARMA GROUP LTD. is an international pharmaceutical company dedicated to the research, development, manufacturing, and sale of innovative medications. The company focuses on therapeutic areas including the central nervous system, oncology, and cardiovascular diseases, alongside orthopaedics, neurology, and gastroenterology. Its product portfolio, comprising over 50 products, addresses various medical conditions such as schizophrenia, depression, and cancer. A key strength lies in its expertise in high-barrier delivery systems like microspheres and liposomes. With global R&D centers, Luye Pharma is actively advancing its pipeline, including novel molecular entities like LY03015 and LY03017 for conditions such as Alzheimer’s Disease-related Psychosis, and has achieved approvals for products like Rykindo® (LY03004) in major markets. Its business operations extend across more than 80 countries and regions worldwide.

Recent filings

Filing Released Lang Actions
Bondholder's Early Redemption (Put Option)::Voluntary
Regulatory Filings
2025-09-10 English
Bondholder's Early Redemption (Put Option)::Voluntary
Regulatory Filings
2025-09-09 English
Bondholder's Early Redemption (Put Option)::Voluntary
Regulatory Filings
2025-08-20 English
Bondholder's Early Redemption (Put Option)::Voluntary
Regulatory Filings
2025-08-14 English
Bondholder's Early Redemption (Put Option)::Voluntary
Regulatory Filings
2025-08-01 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.